An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis
Status:
Completed
Trial end date:
2017-03-22
Target enrollment:
Participant gender:
Summary
The objective of this study was to evaluate the safety and therapeutic equivalence of generic
ingenol mebutate gel, 0.015% to Picato gel, 0.015% by establishing the therapeutic
comparability of the two active products and the superiority of the two active products over
the vehicle gel in the treatment of AK on the face and scalp.